Citation: Kl. Napoli et al., RELATIVE TISSUE DISTRIBUTIONS OF CYCLOSPORINE AND SIROLIMUS AFTER CONCOMITANT PERORAL ADMINISTRATION TO THE RAT - EVIDENCE FOR PHARMACOKINETIC INTERACTIONS, Therapeutic drug monitoring, 20(2), 1998, pp. 123-133
Authors:
KAHAN BD
PODBIELSKI J
NAPOLI KL
KATZ SM
MEIERKRIESCHE HU
VANBUREN CT
Citation: Bd. Kahan et al., IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS CYCLOSPORINE COMBINATION REGIMEN FOR RENAL-TRANSPLANTATION/, Transplantation, 66(8), 1998, pp. 1040-1046
Authors:
KAPLAN B
MEIERKRIESCHE HU
NAPOLI KL
KAHAN BD
Citation: B. Kaplan et al., THE EFFECTS OF RELATIVE TIMING OF SIROLIMUS AND CYCLOSPORINE MICROEMULSION FORMULATION COADMINISTRATION ON THE PHARMACOKINETICS OF EACH AGENT, Clinical pharmacology and therapeutics, 63(1), 1998, pp. 48-53
Authors:
GOODYEAR N
NAPOLI KL
MURTHY JN
KAHAN BD
SOLDIN SJ
Citation: N. Goodyear et al., RADIORECEPTOR ASSAY FOR SIROLIMUS IN PATIENTS WITH DECREASED PLATELETCOUNTS, Clinical biochemistry, 30(7), 1997, pp. 539-543
Authors:
STEPKOWSKI SM
TIAN L
NAPOLI KL
GHOBRIAL R
WANG ME
CHOU TC
KAHAN BD
Citation: Sm. Stepkowski et al., SYNERGISTIC MECHANISMS BY WHICH SIROLIMUS AND CYCLOSPORINE INHIBIT RAT-HEART AND KIDNEY ALLOGRAFT-REJECTION, Clinical and experimental immunology, 108(1), 1997, pp. 63-68
Citation: Kl. Napoli et al., AN APPROPRIATE STATISTICAL APPROACH FOR THE COMPARISON OF FPIA TO HPLC FOR DETERMINATION OF CYCLOSPORINE CONCENTRATIONS IN ANIMAL-TISSUES, Journal of clinical ligand assay, 19(3), 1996, pp. 190-197
Authors:
STEPKOWSKI SM
NAPOLI KL
WANG ME
QU XM
CHOU TC
KAHAN BD
Citation: Sm. Stepkowski et al., EFFECTS OF THE PHARMACOKINETIC INTERACTION BETWEEN ORALLY-ADMINISTERED SIROLIMUS AND CYCLOSPORINE ON THE SYNERGISTIC PROLONGATION OF HEART ALLOGRAFT SURVIVAL IN RATS, Transplantation, 62(7), 1996, pp. 986-994
Citation: Kl. Napoli et al., SAFETY AND EFFICACY OF CHLORAL HYDRATE SEDATION IN CHILDREN UNDERGOING ECHOCARDIOGRAPHY, The Journal of pediatrics, 129(2), 1996, pp. 287-291
Authors:
STREIT F
CHRISTIANS U
SCHIEBEL HM
NAPOLI KL
ERNST L
LINCK A
KAHAN BD
SEWING KF
Citation: F. Streit et al., SENSITIVE AND SPECIFIC QUANTIFICATION OF SIROLIMUS (RAPAMYCIN) AND ITS METABOLITES IN BLOOD OF KIDNEY GRAFT RECIPIENTS BY HPLC ELECTROSPRAYMASS-SPECTROMETRY, Clinical chemistry, 42(9), 1996, pp. 1417-1425
Citation: Kl. Napoli et Bd. Kahan, ROUTINE CLINICAL MONITORING OF SIROLIMUS (RAPAMYCIN) WHOLE-BLOOD CONCENTRATIONS BY HPLC WITH ULTRAVIOLET DETECTION, Clinical chemistry, 42(12), 1996, pp. 1943-1948
Citation: Ss. Ahmed et al., OXYGEN RADICAL FORMATION DURING CYTOCHROME P450-CATALYZED CYCLOSPORINE METABOLISM IN RAT AND HUMAN LIVER-MICROSOMES AT VARYING HYDROGEN-IONCONCENTRATIONS, Molecular and cellular biochemistry, 151(2), 1995, pp. 131-140
Citation: Kl. Napoli et Bd. Kahan, SAMPLE CLEANUP AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC TECHNIQUESFOR MEASUREMENT OF WHOLE-BLOOD RAPAMYCIN CONCENTRATIONS, Journal of chromatography B. Biomedical applications, 654(1), 1994, pp. 111-120
Authors:
SERINO F
GREVEL J
NAPOLI KL
KAHAN BD
STROBEL HW
Citation: F. Serino et al., OXYGEN RADICAL FORMATION BY THE CYTOCHROME-P450 SYSTEM AS A CELLULAR MECHANISM FOR CYCLOSPORINE TOXICITY, Transplantation proceedings, 26(5), 1994, pp. 2916-2917
Authors:
SERINO F
GREVEL J
NAPOLI KL
KAHAN BD
STROBEL HW
Citation: F. Serino et al., GENERATION OF OXYGEN-FREE RADICALS DURING THE METABOLISM OF CYCLOSPORINE-A - A CAUSE-EFFECT RELATIONSHIP WITH METABOLISM INHIBITION, Molecular and cellular biochemistry, 122(2), 1993, pp. 101-112
Citation: Ss. Ahmed et al., ADRENOCHROME REACTION IMPLICATES OXYGEN RADICALS IN METABOLISM OF CYCLOSPORINE-A AND FK-506 IN RAT AND HUMAN LIVER-MICROSOMES, The Journal of pharmacology and experimental therapeutics, 265(3), 1993, pp. 1047-1054